{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:12:09Z","timestamp":1790435529842,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Mallinckrodt"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCB"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Mallinckrodt"},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jaad.2020.06.081","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T02:05:32Z","timestamp":1593050732000},"page":"1599-1605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Family history of psoriasis, psychological stressors, and tobacco use are associated with the development of tumor necrosis factor-\u03b1 inhibitor-induced psoriasis: A case-control study"],"prefix":"10.1016","volume":"83","author":[{"given":"Jason","family":"Ya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery Z.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Nowacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmi","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Mazloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowri","family":"Kabbur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elaine","family":"Husni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.06.081_bib1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-2133.2009.09329.x","article-title":"Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments","volume":"161","author":"Seneschal","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.06.081_bib2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archdermatol.2011.275","article-title":"Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of two cases","volume":"147","author":"Chu","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2020.06.081_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archderm.143.2.223","article-title":"Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions","volume":"143","author":"de Gannes","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2020.06.081_bib4","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1365-2036.2011.04866.x","article-title":"Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature","volume":"34","author":"Cullen","year":"2011","journal-title":"Ailment Pharmacol Ther"},{"key":"10.1016\/j.jaad.2020.06.081_bib5","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jaad.2011.05.038","article-title":"Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-\u03b1 inhibitors: the Mayo Clinic experience, 1998-2010","volume":"67","author":"Shmidt","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.06.081_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.crohns.2012.08.007","article-title":"Induction of exacerbation of psoriatic lesions during anti-TNF-\u03b1 therapy for inflammatory bowel disease: a systemic literature review based on 222 cases","volume":"7","author":"Denadai","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jaad.2020.06.081_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semarthrit.2010.04.003","article-title":"Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis","volume":"40","author":"Collamer","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.06.081_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","article-title":"Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterized by interferon-\u03b3-expressing Th1 cells and IL-17A\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment","volume":"63","author":"Tillack","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jaad.2020.06.081_bib9","doi-asserted-by":"crossref","unstructured":"Mazloom SE, Yan D, Hu JZ, et\u00a0al. TNF-alpha inhibitor-induced psoriasis: A decade of experience at the Cleveland Clinic [e-pub ahead of print]. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2018.12.018. Accessed January 12, 2020.","DOI":"10.1016\/j.jaad.2018.12.018"},{"key":"10.1016\/j.jaad.2020.06.081_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/archderm.143.2.233","article-title":"The yin and yang of TNF-\u03b1 inhibition","volume":"143","author":"Fiorentino","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2020.06.081_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41467-017-02466-4","article-title":"TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis","volume":"9","author":"Conrad","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaad.2020.06.081_bib12","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/apt.13352","article-title":"Paradoxical psoriasis in a large cohort of IBD patients treated with anti-TNF alpha: 5 years-follow-up study","volume":"42","author":"Pugliese","year":"2015","journal-title":"Ailment Pharmacol Ther"},{"key":"10.1016\/j.jaad.2020.06.081_bib13","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/MIB.0000000000000757","article-title":"Incidence, clinical characteristics, and management of psoriasis induced by anti-TNF therapy in patients with inflammatory bowel disease: a nationwide cohort study","volume":"22","author":"Guerra","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaad.2020.06.081_bib14","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2010.07.022","article-title":"Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy","volume":"8","author":"Rahier","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2020.06.081_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000342503","article-title":"Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature","volume":"225","author":"Osario","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2020.06.081_bib16","first-page":"700","article-title":"Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?","volume":"30","author":"Joyau","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2020.06.081_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/apt.13542","article-title":"Genetic basis of TNF-\u03b1 antagonist associated psoriasis in inflammatory bowel diseases: a genotype-phenotype analysis","volume":"43","author":"Vedak","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaad.2020.06.081_bib18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/tpj.2015.53","article-title":"Paradoxical psoriasiform reactions to anti-TNF\u03b1 drugs are associated with genetic polymorphisms in patients with psoriasis","volume":"16","author":"Cabaleiro","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaad.2020.06.081_bib19","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.2018.7028","article-title":"Association of stress-related disorders with subsequent autoimmune disease","volume":"319","author":"Song","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2020.06.081_bib20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrendo.2012.189","article-title":"The vagus nerve and the inflammatory reflex: linking immunity and metabolism","volume":"8","author":"Pavlov","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jaad.2020.06.081_bib21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1365-2133.2010.09984.x","article-title":"How stress gets under the skin: cortisol and stress reactivity in psoriasis","volume":"163","author":"Evers","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.06.081_bib22","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/jid.2008.460","article-title":"Effect of daily stressors on psoriasis: a prospective study","volume":"129","author":"Verhoeven","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.06.081_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2017.04.015","article-title":"Smoking and risk of psoriasis: a nationwide cohort study","volume":"77","author":"Lee","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 3","key":"10.1016\/j.jaad.2020.06.081_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jdv.12164","article-title":"Alcohol consumption and psoriasis: a systematic literature review","volume":"27","author":"Brenaut","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2020.06.081_bib25","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1111\/acer.12201","article-title":"Mechanisms by which chronic ethanol feeding impairs the migratory capacity of cutaneous dendritic cells","volume":"37","author":"Parlet","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jaad.2020.06.081_bib26","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/acer.12358","article-title":"Chronic ethanol feeding induces subset loss and hyporesponsiveness in skin T cells","volume":"38","author":"Parlet","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jaad.2020.06.081_bib27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1530-0277.2010.01376.x","article-title":"Ethanol changes gene expression of transcription factors and cytokine production of CD4+ T-cell subsets in PBMCs stimulated with LPS","volume":"35","author":"von Haefen","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jaad.2020.06.081_bib28","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.3748\/wjg.v20.i22.7019","article-title":"Correlations between skin lesions induced by anti-tumor necrosis factor-\u03b1 and selected cytokines in Crohn\u2019s disease patients","volume":"20","author":"Wlodarczyk","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaad.2020.06.081_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00128071-200809010-00001","article-title":"Tumor necrosis factor-\u03b1 inhibitor-induced psoriasis or psoriasiform exanthemata first 120 cases from the literature including a series of six new patients","volume":"9","author":"Wollina","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2020.06.081_bib30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/09546630802441234","article-title":"Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases","volume":"20","author":"Ko","year":"2009","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaad.2020.06.081_bib31","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1007\/s00296-011-2265-4","article-title":"Psoriasis and psoriasiform lesions induced by TNF\u03b1 antagonists: the experience of a tertiary care hospital from northern Spain","volume":"32","author":"Lopez-Robles","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaad.2020.06.081_bib32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2230.2006.02315.x","article-title":"Flare and change in psoriasis morphology during the course of treatment with tumour necrosis factor blockers","volume":"32","author":"Goiriz","year":"2006","journal-title":"Clin Exp Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220311804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220311804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:55:01Z","timestamp":1759272901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220311804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0190962220311804"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.06.081","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Family history of psoriasis, psychological stressors, and tobacco use are associated with the development of tumor necrosis factor-\u03b1 inhibitor-induced psoriasis: A case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.06.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}